Subjects: CIRROSE HEPÁTICA, NEOPLASIAS HEPÁTICAS, CARCINOMA HEPATOCELULAR
ABNT
ALENCAR, Regiane Saraiva de Souza Melo et al. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series. Clinics, v. 77, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50508. Acesso em: 18 nov. 2024.APA
Alencar, R. S. de S. M., Oliveira, C. P., Chagas, A. L., Fonseca, L. G. da, Maccali, C., Saud, L. R. da C., et al. (2022). Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series. Clinics, 77. doi:10.1016/j.clinsp.2022.100097NLM
Alencar RS de SM, Oliveira CP, Chagas AL, Fonseca LG da, Maccali C, Saud LR da C, Xerfan MP, Stefano JT, Herman P, D'albuquerque LAC. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series [Internet]. Clinics. 2022 ; 77[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50508Vancouver
Alencar RS de SM, Oliveira CP, Chagas AL, Fonseca LG da, Maccali C, Saud LR da C, Xerfan MP, Stefano JT, Herman P, D'albuquerque LAC. Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series [Internet]. Clinics. 2022 ; 77[citado 2024 nov. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50508